The result: ‘personalized medicine,’ this means patients get remedies that benefit them particularly and they avoid remedies – including their costs and side effects – that are not likely to make a difference for them. Related StoriesMD Anderson study reveals why chemotherapy medications not effective for many pancreatic cancer patientsSausages With Antioxidants From Berries TO AVOID CancerCornell biomedical engineers develop 'super natural killer cells' to destroy cancers cells in lymph nodes The regulatory procedure, the extensive analysis funding, the reimbursement, even the standards for journal publications for tumor biomarker tests are all meager compared to the robust support for drug development, the authors say.When you can control the insulin-signaling pathway with a medication, that could make your life easier. Three targets Many excellent scientists share this objective, but up to now the field provides fallen short. Still, for all the well-worn dead ends, Peti still views the insulin-signaling pathway as rife with potential brand-new leads. He plans to look in novel methods and in novel areas at the interactions of three main proteins in particular. Related StoriesWeight-loss surgery could be safe for managing type 2 diabetes in sufferers with moderate obesityNew Cleveland Clinic research shows bariatric medical procedures is safe option for managing type 2 diabetes in over weight or mildly obese patientsType 2 diabetes drug considerably reduces hospitalizations, death from heart failure One target may be the binding between insulin and the insulin receptor.